Rehmann Capital Advisory Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$28.2K Sell
494
-2,111
-81% -$140K ﹤0.01% 783
2019
Q2
$170K Buy
2,605
+2,173
+503% +$151K 0.02% 467
2019
Q1
$32K Sell
432
-14
-3% -$984 ﹤0.01% 967
2018
Q4
$26.6K Sell
446
-605
-58% -$48.8K ﹤0.01% 786
2018
Q3
$99.2K Sell
1,051
-13
-1% -$1.12K 0.01% 590
2018
Q2
$79.9K Sell
1,064
-68
-6% -$4.88K 0.01% 626
2018
Q1
$69K Buy
+1,132
New +$61.3K 0.01% 658

Other funds holding HQY

Rehmann Capital Advisory Group's HQY Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its HealthEquity (HQY) stake by 81% in Q3 2019, selling an estimated $140K and leaving 494 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Rehmann Capital Advisory Group first reported a position in HQY in Q1 2018 and has held it in 7 quarters since. The position peaked at $170K in Q2 2019. 303 funds tracked by Wall St. Rank hold HQY as of Q3 2019.

  • Rehmann Capital Advisory Group held 494 shares of HealthEquity worth $28.2K as of Q3 2019.
  • Rehmann Capital Advisory Group sold 2,111 HealthEquity shares in Q3 2019, an estimated $140K.
  • HealthEquity made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #783 holding.
  • Rehmann Capital Advisory Group first reported a position in HealthEquity in Q1 2018 and has held it in 7 quarters since.
  • Rehmann Capital Advisory Group's HealthEquity position peaked at $170K in Q2 2019.
  • 303 funds tracked by Wall St. Rank held HealthEquity as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.